Table 2.
schedule of study visits
| Treatment success | Treatment failure | |
|---|---|---|
| Number of eyes | 11/17 | 6/17 |
| Median age in years (range) | 39 (35–61) | 40.5 (34–53) |
| Gender | 2 female/9 male | 6 male |
| LogMar BCVA at BSL (SD) | 0.14 (± 0.126) | 0.36 (± 0.241) |
| BCVA at last study visit | 0.00 (± 0.126) | 0.30 (± 0.308) |
| Mean CRT at BSL in μm (SD) | 383.09 (± 90.23) | 397.8 (± 158.64) |
| Mean CRT at last study visit in μm (SD) | 240.36 (± 32.47) | 283.6 (± 84.71) |
| Median distance RPE leakage–fovea center in μm (Range) | 1100 (700–4300) | 850 (500–2200) |
| Multiple-/diffuse RPE leakage in FA (%) | 3/11 (27.3%) | 2/6 (33.3%) |
| Median number of initial SRT laser spots (Range) | 10 (6–22) | 8 (6–13) |
| Mean initial SRT treatment energy in μJ (SD) | 133.64 (± 21.86) | 130 (± 20.82) |
| Re-SRT received (%) | 3/11 (27.3%) | 4/6 (66.7%) |
| Mean duration of follow-up in days (SD) | 168.72 (± 123.25) | 168.83 (± 81.18) |